Introducing Fluregiene 200™

14th February 2022

Curtiss-Wright Surface Technologies, Everlube® Coating Products have partnered with BioCote® to expand their fluoropolymer coating product range to create Fluregiene 200™: an antimicrobial coating that is ideally suited for many surfaces and environments.

Based on existing Everlube® coating technology, the new Fluregiene 200™ is a unique fluoropolymer coating that offers low friction, easy-clean properties combined with superb chemical and abrasion resistance. With a view to improving hygiene standards, Everlube® Coatings have integrated BioCote® antimicrobial technology to protect the coating from microbes such as bacteria, mould and fungi. Benefits of applying antimicrobial technology into the Fluregiene 200™ include:


  • Low COF Surface coating (0.08 – 0.2 static)
  • Corrosion resistance and excellent chemical resistance
  • Excellent chip and abrasion resistance
  • Reduces and prevents build-up of contaminates
  • Excellent flexibility
  • Dirt and debris less likely to attach to the surface

Microbial & bacteria growth inhibitor

  • Using patented BioCote® antimicrobial technology against microbial growth
  • Inhibits and reduces microbial growth on protected coating
  • Protects treated surfaces against bad odours, staining and material degradation

Easy clean and reduced cleaning intervals

  • Provides continual microbial reduction on coating
  • High PTFE content allows easy wipe down and cleaning
  • Provides more hygienic and cleanable surface than brushed or finished steels

Applicable to a wide range of parts and components such as door handles, elevator buttons, airport seating and gym equipment, the Fluregiene 200™ will be highly beneficial for these surfaces. BioCote® also has real-life data to support the application of this antimicrobial technology in environments such as health care, transport, education, public areas and much more.

For more information on Fluregiene 200™ and Everlube® Coating Products please contact our coatings team on:

<< Back to News Archives